INITIATOR CELLS IN DELAYED-TYPE HYPERSENSITIVITY
迟发型超敏反应的起始细胞
基本信息
- 批准号:2063491
- 负责人:
- 金额:$ 24.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-04-01 至 1997-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Delayed-type hypersensitivity (DTH) responses are a model of CD4+ T cell
recruitment into the tissues in immune resistance and in allergic and
autoimmune diseases. The presence of sensitized CD4+, DTH effector T cells
in the circulation is not sufficient for recruitment into a tissue site
challenged with antigen (Ag). Another Ag-specific cell called DTH-
initiating cells is required. These cells elaborate Ag-specific factors
that are analogous to IgE antibody and mediate DTH-initiation by leading to
local release of the vasoactive amine serotonin. Using a panel of
monoclonal antibodies to deplete DTH-initiating activity, an unusual
phenotype for an Ag-specific cell was found: Thy-1+, CD5+, CD4-, CD8-,
CD3epsilon-, sIg-, B220+, I1-2R-, and IL-3R+. Furthermore, DTH-initiating
cells were induced in athymic nude mice but not in SCID mice, leading to
the conclusion that DTH-initiating cells were primitive, relatively thymic
independent, Ag-specific cells that employed rearranging genes to encode
the Ag-specific factors that mediate DTH-initiation. Nude mice were used
to immunize and boost DTH-initiating cells in the absence of contaminating
CD4+ DTH-effector T cells, or CD8+ suppressor T cells that down-regulate
DTH-initiating cells, and in vitro lines and clones of DTH-initiating cells
were generated. the phenotype of the DTH- clones determined by FACS and
molecular analysis confirmed that DTH-initiating cells are primitive Ag-
specific cells of a unique mixed phenotype: for T-like markers: Thy-1+,
CD5+, CD4-, CD8-, surface and mRNA CD3-, surface and mRNA alphabeta TCR-
and delta TCR mRNA+; for B-like markers: surface and mRNA Ig-, B220+,
CD23-; and for Mphi markers FcgammaR+, Mac1+, Class II+.
The current specific aims are to: 1) Develop DTH-initiating clones of
another Ag specificity to confirm Ag-specificity of DTH-initiation at the
clonal level. 2) To clone, sequence, and express the product of the TCR-
delta hybridizing gene that is transcribed in the DTH-initiating clones.
3) To clone the gene(s) that encode the DTH-initiating factors. An
unamplified cDNA library will be constructed from the DTH-initiating clone
in lambdalZAP and will be screened by several means to attempt to isolate
cDNA(s) encoding the Ag specific DTH-initiating factor. Probing will be
attempted with a polyclonal antibody for DTH-initiating factors, and also
with a ligand probe consisting of a conjugate of the relevant hapten
coupled to albumin to which is also linked alkaline phosphatase. Attempts
will continue to biochemically purify the DTH-initiating factor to obtain
amino acid sequence information to construct an oligonucleotide probe.
Finally, hamster monoclonal antibodies will be developed to DTH-initiating
factor to provide monospecific reagents to screen the library. It is thus
hoped that knowledge will be advanced of the important in vivo phenomena of
DTH-initiation to the level of molecular cloning of the biologically
relevant molecule.
迟发型超敏反应(DTH)是一种CD 4 + T细胞免疫反应模型。
招募到组织中的免疫抵抗和过敏,
自身免疫性疾病 致敏的CD 4+、DTH效应T细胞的存在
不足以募集到组织部位
用抗原(Ag)攻击。 另一种Ag特异性细胞称为DTH-
需要启动细胞。 这些细胞产生银特异性因子
其类似于IgE抗体并通过导致
局部释放血管活性胺血清素。 使用一组
单克隆抗体消耗DTH起始活性,一种不寻常的
发现Ag特异性细胞的表型:Thy-1+,CD 5+,CD 4-,CD 8-,
CD3 β-、sIg-、B220+、I1-2R-和IL-3R+。 此外,DTH启动
细胞在无胸腺裸鼠中诱导,但在SCID小鼠中未诱导,导致
结论DTH起始细胞是原始的,相对胸腺
独立的,Ag特异性细胞,采用重排基因编码
介导DTH起始的Ag特异性因子。 使用裸鼠
在没有污染的情况下免疫和加强DTH起始细胞,
CD 4 + DTH效应T细胞,或CD 8+抑制性T细胞,
DTH起始细胞,以及DTH起始细胞的体外系和克隆
产生了。 通过FACS测定DTH克隆的表型,
分子分析证实DTH起始细胞是原始的Ag-
独特混合表型的特定细胞:对于T样标记:Thy-1+,
CD 5+、CD 4-、CD 8-、表面和mRNA CD 3-、表面和mRNA α TCR-
和δ TCR mRNA+;对于B样标志物:表面和mRNA IG-,B220+,
CD 23-;以及对于Mphi标志物Fc γ R+,Mac 1+,II类+。
目前的具体目标是:1)开发DTH启动克隆,
另一种Ag特异性,以确认在
克隆水平 2)为了克隆、测序和表达TCR-1的产物,
在DTH起始克隆中转录的δ杂交基因。
3)目的:克隆编码迟发型超敏反应起始因子的基因。 一个
将从DTH起始克隆构建未扩增的cDNA文库
将通过几种方法进行筛选,以尝试分离
编码抗原特异性DTH起始因子的cDNA。 探测将是
尝试用DTH起始因子的多克隆抗体,
配体探针由相关半抗原的缀合物组成
与白蛋白偶联,白蛋白还与碱性磷酸酶连接。 尝试
将继续生化纯化DTH引发因子,
氨基酸序列信息以构建寡核苷酸探针。
最后,仓鼠单克隆抗体将被开发用于DTH启动
因子以提供单特异性试剂来筛选文库。 因此
希望知识将先进的重要体内现象,
DTH-生物学分子克隆水平的启动
相关分子
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHILIP William ASKENASE其他文献
PHILIP William ASKENASE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHILIP William ASKENASE', 18)}}的其他基金
Initiation of Contact and Asthmatic Hypersensitivity
接触的开始和哮喘过敏
- 批准号:
7183609 - 财政年份:2004
- 资助金额:
$ 24.49万 - 项目类别:
Initiation of Contact and Asthmatic Hypersensitivity
接触的开始和哮喘过敏
- 批准号:
7023890 - 财政年份:2004
- 资助金额:
$ 24.49万 - 项目类别:
Initiation of Contact and Asthmatic Hypersensitivity
接触的开始和哮喘过敏
- 批准号:
7367191 - 财政年份:2004
- 资助金额:
$ 24.49万 - 项目类别:
Initiation of Contact and Asthmatic Hypersensitivity
接触的开始和哮喘过敏
- 批准号:
6861027 - 财政年份:2004
- 资助金额:
$ 24.49万 - 项目类别:
Initiation of Contact and Asthmatic Hypersensitivity
接触的开始和哮喘过敏
- 批准号:
6759076 - 财政年份:2004
- 资助金额:
$ 24.49万 - 项目类别:
INITIATOR T CELLS IN DELAYED-TYPE HYPERSENSITIVITY
迟发型超敏反应中的启动 T 细胞
- 批准号:
3140567 - 财政年份:1989
- 资助金额:
$ 24.49万 - 项目类别:
INITIATOR CELLS IN DELAYED-TYPE HYPERSENSITIVITY
迟发型超敏反应的起始细胞
- 批准号:
2063492 - 财政年份:1989
- 资助金额:
$ 24.49万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 24.49万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 24.49万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 24.49万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 24.49万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 24.49万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 24.49万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 24.49万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 24.49万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 24.49万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 24.49万 - 项目类别:
Discovery Grants Program - Individual